July 18, 2006 – NanoInk Inc. announced the appointment of Robert Janosky as the company’s president and chief operating officer. Janosky will be responsible for guiding NanoInk’s operations and will report to Cedric Loiret-Bernal, the company’s chief executive officer.
Janosky brings more than 35 years of operational experience and significant pharmaceutical manufacturing expertise to NanoInk. Most recently, he served as vice president, manufacturing at Cubist Pharmaceuticals, a publicly traded biopharmaceutical company focused on developing and commercializing anti-infective therapies for the acute care environment.
Previously, Janosky was vice president, manufacturing at Warner Lambert and also served as the president and general manager of the company’s Puerto Rico location. Additionally he has held other senior management positions with Cardinal Health, Rhone Poulenc-Rorer and Bristol Myers.